29 July 2021 Blog UK regulator cracks down on anti-competitive practices UK watchdog, the Competition and Markets Authority (CMA), is coming down hard on anti-competitive pricing practices. Following hot on the heels of fines totalling over £260m for competition breaches relating to the supply of hydrocortisone tablets... Share this article Bookmark this page 2 min read
8 July 2021 Blog A new subsidy control system Simon Elsegood explains how this will change public sector investment aimed at developing the economy, following the UK's departure from the EU... Share this article Bookmark this page 1 min read
6 July 2021 Blog UK plans to boost pharmacovigilance and data collection on medicines The UK Government has published draft legislation targeting a major restructuring of the National Health Service. This will see the abolition of CCGs (Clinical Commissioning Groups) and the creation of statutory Integrated Care Systems (ICSs). Share this article Bookmark this page 2 min read
27 June 2021 Blog Data protection adequacy decisions - just in time The EU has adopted final versions of the two adequacy decisions that were issued in draft earlier this year. These permit personal data flows to the UK under the GDPR and the Law Enforcement Directive. Share this article Bookmark this page 1 min read
6 June 2021 Blog The 2021 ABPI Code takes effect soon The UK pharma sector is readying itself for the introduction of the new ABPI Code, bringing in extensive changes to the industry's self-regulatory system. Share this article Bookmark this page 1 min read
6 June 2021 Blog Plans for a multilateral pharmaceutical merger task force The aim is to identify concrete and actionable steps to review and update the analysis of pharmaceutical mergers, and address perceived harms around price increases and anti-competitive conduct. Share this article Bookmark this page 2 min read
24 May 2021 Blog EU Parliament calls for review of UK's data privacy regime The European Parliament has asked the EU Commission to take another look at the UK's data protection adequacy assessment. Share this article Bookmark this page 1 min read
18 May 2021 Blog Issues to consider when exploiting commercial opportunities in People’s Republic of China As the Chinese life sciences market continues to grow and develop, the Chinese government continues to de-regulate or streamline its regulatory pathways (such as its drug approval regimes). And as Chinese parties seek to exploit foreign technologies... Share this article Bookmark this page 4 min read
22 April 2021 Blog EU bid to control the future of AI This week saw the publication of long-expected draft EU legislation aimed at regulating artificial intelligence systems of all kinds. These broad proposals indicate a willingness to take an... Share this article Bookmark this page 1 min read
22 April 2021 Blog UK considers reform to GMO regulations As explained in DEFRA’s supporting documents, GMOs generally involve the introduction of genetic material into an organism. The classic example is lifting DNA from one species and inserting into a... Share this article Bookmark this page 3 min read
10 March 2021 Blog Next steps for life sciences regulation in the UK As the UK's Medicines and Medical Devices Act 2021 becomes law, we review what... Share this article Bookmark this page 1 min read
22 February 2021 Blog Good news for EEA/UK personal data flows The EU Commission has now published draft adequacy decisions for transfers of personal data to the United Kingdom, under both the GDPR and the Law Enforcement Directive. This is welcome news, as it will provide a greater degree of certainty... Share this article Bookmark this page 2 min read